Akebia Therapeutics AKBA Q1 2026 Earnings EPS Misses Estimates Amidst Flat Stock Reaction Laird Superfood Inc Q1 2026 Earnings Surprise Profitability Demonstrated Through Strong Cost Controls CG Q1 2026 Earnings Earnings Miss Expectations Despite Modest Stock Gain ACNB Q1 2026 Earnings EPS Beat Estimate Despite Slight Stock Decline PUK Q4 2025 Earnings EPS Misses Estimates by 2917 Amid Market Headwinds WWW Q1 2026 Earnings EPS Exceeds Estimates Positive Market Response